Scientists reversed advanced Alzheimer's in mice using a compound that restores cellular energy. The breakthrough challenges ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...

A new compound has been shown to reverse late stage Alzheimer's disease in lab mice, which gives millions of sufferers new ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Since its discovery, Alzheimer's disease has been considered irreversible. Consequently, research has focused on preventing ...

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A ...

More than seven million Americans have Alzheimer's disease, and two-thirds of them are women, according to the Alzheimer's Association. The O'Banion Lab at the Del Monte Institute for Neuroscience at ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence ...

A study published in Nature looks at the prevalence of Alzheimer’s Disease pathology in the community. Prof Roslyn Bill, Professor of Biotechnology, Aston University, said: ...

Data from a disease model showed that HSV1 infection caused tau hyperphosphorylation, forming aggregates that trapped viral ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...